Implications of Time Interval from Atrial Fibrillation Ablation to Early Recurrence on Incidence of Late Recurrence

Predictors of late recurrence of atrial fibrillation after catheter ablation.

BACKGROUND To predict the recurrence of atrial fibrillation is important for selecting patients who will be undergoing catheter ablation, several studies respectively evaluated the risk factor of the recurrence of atrial fibrillation post-ablation. OBJECTIVE To investigate the factors predicting the recurrence of atrial fibrillation (AF) after catheter ablation. METHODS 186 patients (55.12 ...

Catheter Ablation for Atrial Fibrillation: Predicting Recurrence

Predictors of Recurrence After Catheter Ablation of Persistent Atrial Fibrillation.

Catheter ablation of atrial fibrillation (AF) has been increasingly used to treat symptomatic patients.Within the last years a growing interest in ablation of persistent AF forms has evolved.Factors that may influence outcome of these procedures to treat persistent AF may be patient-specific (pre-procedural),procedure-related or may involve different post-ablation followup strategies. In this r...

Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.

BACKGROUND Although catheter ablation (CA) is a standard treatment for atrial fibrillation (AF), its long-term efficacy remains unclear. This study aimed to elucidate the incidences of AF recurrence and of progression from paroxysmal to persistent AF, after CA, in patients with paroxysmal AF. METHODS AND RESULTS We examined the incidence of AF recurrence and AF progression in 1220 consecutive...

eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation

PURPOSE Previous studies have demonstrated an association between eNOS polymorphisms and atrial fibrillation (AF). We sought to determine whether eNOS polymorphisms are associated with AF recurrence after a radiofrequency catheter ablation (RFCA). MATERIALS AND METHODS A total of 500 consecutive patients (56±11 years, 77% male) with paroxysmal (68%) or persistent (32%) AF who underwent RFCA a...